The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients
2010 ◽
Vol 137
(4)
◽
pp. 687-694
◽
2014 ◽
Vol 9
(4)
◽
pp. 506-511
◽
2003 ◽
Vol 13
(5)
◽
pp. 289-298
◽